Trypsin-Chymotrypsin 100000 units of enzymatic activity
| Composition | Trypsin-Chymotrypsin 100000 units of enzymatic activity |
|---|---|
| Packing | 10x10 ALU/ALU |
| MRP | ₹ 2100 |
| Dosage Form | Tablets |
Trypfix Tablet is an anti-inflammatory enzyme tablet containing Trypsin-Chymotrypsin 100,000 units of enzymatic activity. This combination of two proteolytic enzymes — Trypsin and Chymotrypsin — works by breaking down proteins involved in inflammation and oedema at injury or surgical sites, supporting the body's natural healing process.
Trypfix is commonly prescribed as an adjunct therapy to reduce post-operative, post-traumatic, and inflammatory swelling and bruising. The dual enzyme formula provides complementary proteolytic activity across a broader range of protein substrates, potentially offering more complete anti-oedematous action compared to single-enzyme preparations.
This medicine is commonly used for:
Trypsin-Chymotrypsin combination at 100,000 units enzymatic activity is indicated as an adjunct anti-oedematous and anti-inflammatory agent in post-operative oedema, post-traumatic swelling, haematomas, inflammatory musculoskeletal conditions, and dental surgical recovery. The proteolytic activity facilitates fibrinolysis, degradation of inflammatory mediators, and resolution of exudative oedema, supporting faster tissue repair.
Trypfix contains two powerful natural enzymes — Trypsin and Chymotrypsin — that, when absorbed into the bloodstream, travel to sites of inflammation and injury. There, they break down proteins that make up the fluid and debris that accumulate in swollen tissue. By clearing this inflammatory protein buildup, the swelling reduces, blood circulation to the area improves, and the healing process is accelerated.
Trypsin is a serine endopeptidase that cleaves peptide bonds at the carboxyl side of lysine and arginine residues, degrading fibrin, fibrinogen, bradykinin, complement proteins, and pro-inflammatory cytokines. Chymotrypsin cleaves at the carboxyl side of aromatic and bulky hydrophobic amino acid residues (phenylalanine, tryptophan, tyrosine), targeting a complementary set of inflammatory substrates. Administered orally and absorbed via the GI mucosa into systemic circulation, the two enzymes act synergistically at inflammatory loci to reduce oedematous protein accumulation, modulate neutrophil migration, and support microvascular permeability normalisation. This facilitates fibrinolysis and accelerated resolution of post-inflammatory exudate.
Chymotrypsin, one of the enzymes in Trypfix, was among the first enzymes to be crystallised in pure form (by Nobel laureate James Sumner and John Northrop in the 1930s), paving the way for the understanding of enzyme-based therapies in medicine.
Trypfix Tablet should ideally be taken on an empty stomach — at least 30 minutes before a meal or 2 hours after — so the enzymes are absorbed into the bloodstream rather than used for digestion, unless your doctor advises otherwise. Follow the dosage and duration prescribed by your doctor exactly.
Always follow the dosage and schedule advised by your doctor — this is general guidance only.
Trypfix is generally well-tolerated. Some people may experience mild nausea, stomach discomfort, or loose stools. Allergic reactions are rare but possible. Tell your doctor if any side effect is severe or persistent.
Enzyme tablets work only when taken with food.
Proteolytic enzymes like Trypsin-Chymotrypsin are best absorbed on an empty stomach. When taken with food, they are largely used to digest food rather than being absorbed into the bloodstream to act on inflammation.
Enzyme anti-inflammatory tablets are just digestive aids with no real medical use.
Systemically absorbed proteolytic enzymes are clinically studied for their anti-oedematous and anti-inflammatory properties and are widely used in post-surgical and trauma care as adjunct treatments.